Honourees span API development, finished formulation, supply chain, sustainable innovation and leadership excellence.
Informa has announced the winners of the CPHI Pharma Awards 2026, recognising companies and individuals who have delivered innovation and progress across the global pharmaceutical industry.
Unveiled at this year’s event in Milan—following confirmation of the finalists in September—the winners span 15 categories, across drug delivery, devices and packaging, digital transformation, manufacturing, supply chain, sustainability, collaboration and leadership.
Tara Dougal, Events Director, Pharma Portfolio at Informa Markets said: “With 15 categories recognising achievements ranging from scientific and manufacturing innovation to sustainability and individual leadership, this year’s winners demonstrate the breadth of expertise, innovation and collaboration driving pharma forward. Congratulations to all of our winners and finalists.”
Loic Bishop, Global Change Facilitator at BioPhorum, and one of the judges for the 2026 awards, said: “The standard of submissions this year demonstrated both the pace of innovation across pharma and the increasingly collaborative way in which the industry is tackling its biggest challenges. Selecting the winners required us to look beyond individual achievements and consider the wider impact each entry could have on patients, partners and the future of the sector. The strength of the finalists made that an exceptionally difficult task.”
Category winners
API Development: MODAG - Combined platform for neurodegeneration: PD DETECT® (SAA early diagnostics) & Emrusolmin (disease-modifying therapy)
Digital transformation: Evonik - Evonik Self Driving Labs
Drug delivery, devices & packaging innovation: ForgeStop - ForgeStop Ă— EM Microelectronic - Secure Connected Packaging for Pharmaceutical Track-and-Trace and Authentication
Excellence with purpose: Medical and Pharmaceutical Industry Development Agency, Ministry of Health of Uzbekistan - Making Medicines Affordable in Uzbekistan: Reference Pricing, Digital Monitoring and Public Access
Finished formulation: SeraNovo - NanoGlass™, a formulation platform for oral BCS IV and bRo5 drugs
Innovation catalyst: Touchlight - Touchlight’s cell-free Doggybone™ DNA (dbDNA™) platform
Manufacturing excellence: Anemocyte - AMCAP : Evolving the enzymatic mRNA manufacturing
Supply chain excellence: Almac Clinical Services - Zero Margin for Error: Supply Chain Excellence in Ultra-Rare Gene Therapy with Almac Adapt™
Sustainable pharma excellence: Celtic Renewables - Leading the green chemical revolution
Sustainable transformation Partnership: AstraZeneca - Further Together: Partnering for Systemic Change
True PARTNERSHIP Excellence: Aurigene Pharmaceutical Services - Zoliflodacin End-to-End Multiparty Partnership
Start-up initiative: Primogene - Primogene – Cell-Free Enzymatic Biomanufacturing Platform
Future leader: Dr. Pauline van der Wijst-Janssen, Product Development Manager, DFE Pharma
Woman of the year: Emma Charles, Senior Vice President Europe Markets, Bristol Myers Squibb
CEO of the year: Anil Okay, Adalvo
No comments yet